Tablet
Latest Warner-Lambert Company Patents:
- Methods of treating neurofibromatosis type 1 with N-((R))-2,3-dihydroxypropoxy)-3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-benzamide
- COMPOSITIONS OF ESSENTIALLY PURE FORM IV OF N-((R)-2,3-DIHYDROXYPROPOXY)-3,4-DIFLUORO-2-(2-FLUORO-4-IODO-PHENYLAMINO)-BENZAMIDE AND USES THEREOF
- Methods of treating neurofibromatosis with N-((R)-2,3-dihydroxypropoxy)-3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-benzamide
- METHODS OF TREATING NEUROFIBROMATOSIS WITH N-((R)-2,3-DIHYDROXYPROPOXY)-3,4-DIFLUORO-2-(2-FLUORO-4-IODOPHENYLAMINO)-BENZAMIDE
- Compositions of essentially pure form IV of N-((R)-2,3-dihydroxypropoxy)-3,4-difluoro-2-(2-fluoro-4-iodo-phenylamino)-benzamide and uses thereof
Description
FIG. 1 is a bottom perspective view of a tablet;
FIG. 2 is a top perspective view thereof;
FIG. 3 is a bottom plan view thereof;
FIG. 4 is a side elevational view thereof, the opposite side is identical;
FIG. 5 is a front elevational view thereof, the rear elevational view is identical; and,
FIG. 6 is a top plan view thereof.
Referenced Cited
Patent History
Patent number: D356375
Type: Grant
Filed: Sep 24, 1993
Date of Patent: Mar 14, 1995
Assignee: Warner-Lambert Company (Morris Plains, NJ)
Inventors: Kevin S. McGuffy (Stanhope, NJ), Thomas Mathai (Piscataway, NJ)
Primary Examiner: Wallace R. Burke
Assistant Examiner: M. H. Tung
Attorney: Charles W. Almer, III
Application Number: 0/13,476
Type: Grant
Filed: Sep 24, 1993
Date of Patent: Mar 14, 1995
Assignee: Warner-Lambert Company (Morris Plains, NJ)
Inventors: Kevin S. McGuffy (Stanhope, NJ), Thomas Mathai (Piscataway, NJ)
Primary Examiner: Wallace R. Burke
Assistant Examiner: M. H. Tung
Attorney: Charles W. Almer, III
Application Number: 0/13,476
Classifications
Current U.S. Class:
Scored For Dosage Control (D24/103)